In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureus
Authors:
- Marcia S OsburneMOMarcia S Osburne
- David M RothsteinDRDavid M Rothstein
- Ronnie FarquharRFRonnie Farquhar
- Christopher K MurphyCMChristopher K Murphy
- 1 February 2006
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 59 (2) , 80-85
Abstract
Rifalazil is a novel rifamycin that, like other members of this class, inhibits bacterial transcription by targeting the subunit of prokaryotic DNA-dependent RNA polymerase. To address the high-frequency resistance seen with rifamycins, we assessed the ability of rifalazil, alone and in combination with vancomycin, to both kill cells and to suppress the appearance of resistant mutants in log and stationary phase Staphylococcus aureus cultures, using high cell densities in an in vitro kill curve model. We found that 1) rifalazil alone killed log-phase cultures more rapidly than rifampicin, but both drugs quickly selected for resistant mutants, 2) co-treatment of log phase cultures with rifalazil and vancomycin increased bacterial killing by about 3-Log10 over either drug used alone and delayed the appearance of rifamycin-resistant mutants, 3) rifalazil and vancomycin in combination killed stationary phase cultures by 34 Log10 by 48 hours.Keywords
This publication has 9 references indexed in Scilit:
- In Vitro Killing of Community-Associated Methicillin-Resistant Staphylococcus aureus with Drug CombinationsAntimicrobial Agents and Chemotherapy, 2004
- The mutant selection window and antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2003
- Development potential of rifalazilExpert Opinion on Investigational Drugs, 2003
- Phylogenetic, amino acid content and indel analyses of the beta subunit of DNA-dependent RNA polymerase of Gram-positive and Gram-negative bacteriaInternational Journal of Systematic and Evolutionary Microbiology, 2002
- Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococciZentralblatt für Bakteriologie, 1998
- Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clotsAntimicrobial Agents and Chemotherapy, 1996
- In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivativesAntimicrobial Agents and Chemotherapy, 1994
- Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1984
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980